Aquestive Therapeutics' digital transformation strategy centers on enhancing critical operational workflows required for drug development and commercialization. This involves integrating specialized systems to manage rigorous regulatory submissions, streamline clinical data processes, and ensure global pharmaceutical supply chain compliance. Their approach is particularly focused on supporting proprietary PharmFilm® technology products and Contract Development and Manufacturing Organization (CDMO) services.
This transformation introduces critical dependencies on data integrity, system interoperability, and automated controls across their global operations. New regulatory filings and product launches create specific risks for data delays and compliance breakdowns. This page analyzes key initiatives, challenges, and opportunities for engagement arising from Aquestive Therapeutics' evolving digital landscape.
Aquestive Therapeutics Snapshot
Headquarters: Warren, NJ, United States
Number of employees: 147 employees
Public or private: Public
Business model: B2B
Website: http://www.aquestive.com
Aquestive Therapeutics ICP and Buying Roles
Aquestive Therapeutics sells to organizations requiring specialized pharmaceutical drug delivery solutions and manufacturing capabilities, typically complex pharmaceutical developers. They also license their proprietary PharmFilm® technology to other pharmaceutical companies.
Who drives buying decisions
- Chief Medical Officer → Oversees clinical trial strategy and data integrity.
- Vice President, Global Quality And Compliance → Ensures adherence to regulatory standards and quality systems.
- Vice President, Development Operations → Leads operational functions within the drug development group.
- Director, Regulatory Affairs Strategy → Executes regulatory strategy across the product portfolio.
Key Digital Transformation Initiatives at Aquestive Therapeutics (At a Glance)
- Digitalizing regulatory submission document assembly and filing.
- Enhancing clinical trial data collection and analysis from Contract Research Organizations.
- Implementing pharmaceutical product serialization and global traceability across manufacturing sites.
- Automating quality event management workflows within manufacturing operations.
Where Aquestive Therapeutics’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Regulatory Information Management | Digitalizing regulatory submission: documentation versions diverge during multi-country filings. | Director, Regulatory Affairs, VP Global Quality | Validate submission components before health authority review. |
| Digitalizing regulatory submission: health authority feedback requires manual re-categorization. | Director, Regulatory Affairs, Regulatory Operations Manager | Enforce structured data capture for feedback reconciliation. | |
| Digitalizing regulatory submission: audit trails fail to track changes across document lifecycles. | VP Global Quality And Compliance, Director, Regulatory Affairs | Detect unauthorized modifications in submission content. | |
| Clinical Data Platforms | Enhancing clinical data management: raw data fails to sync from CRO systems to internal databases. | Clinical Data Scientist, VP Development Operations | Route clinical data directly into centralized systems. |
| Enhancing clinical data management: human factors study data contains inconsistent participant entries. | Clinical Data Scientist, Chief Medical Officer | Standardize participant data capture fields for study accuracy. | |
| Enhancing clinical data management: pharmacokinetic study outputs require manual transfer to analysis tools. | Clinical Data Scientist, VP Development Operations | Enforce automated data transfers to analytical platforms. | |
| Pharmaceutical Serialization | Implementing serialization: unique product identifiers fail during packaging line integration. | VP of Operations, Supply Chain Director | Detect identifier discrepancies on packaging lines. |
| Implementing serialization: global traceability reports contain missing or incorrect batch data. | Supply Chain Director, VP Global Quality | Validate batch data integrity before global distribution. | |
| Quality Management Systems | Automating quality management: deviations require manual routing for CAPA approval. | VP Global Quality And Compliance, Quality Assurance Manager | Enforce automated routing for quality event escalations. |
| Automating quality management: audit findings do not propagate to corrective action plans. | Quality Assurance Manager, Process Owner | Detect gaps between audit findings and action assignments. |
Identify when companies like Aquestive Therapeutics are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Aquestive Therapeutics’s digital transformation unique
Aquestive Therapeutics' digital transformation uniquely prioritizes stringent regulatory compliance and product launch readiness due to the high-stakes nature of pharmaceutical approvals. Their focus integrates digital tools specifically to support their proprietary PharmFilm® technology across development and manufacturing stages. This approach creates complex interdependencies between R&D, clinical, manufacturing, and regulatory systems, making data integrity and automated process controls critical for market entry and global expansion. The recent Complete Response Letter from the FDA regarding packaging and administration for Anaphylm™ highlights their intense focus on overcoming specific, digitally-addressable hurdles in human factors and packaging design.
Aquestive Therapeutics’s Digital Transformation: Operational Breakdown
DT Initiative 1: Digitalizing Regulatory Submissions
What the company is doing
Aquestive Therapeutics is transforming how it prepares and submits regulatory documents for new drug approvals across various health authorities. This involves moving from less integrated methods to platforms that support electronic common technical document (eCTD) formats. This effort supports new product launches like Anaphylm™ in multiple regions, including the US, Europe, and Canada.
Who owns this
- Director, Regulatory Affairs
- VP Global Quality And Compliance
- Regulatory Operations Manager
Where It Fails
- Regulatory submission documents fail version control during multi-country filings.
- Health authority feedback requires manual re-categorization before system updates.
- Audit trails fail to track changes across document lifecycles during submission cycles.
- Regulatory changes do not propagate to associated manufacturing and quality control procedures.
Talk track
Noticed Aquestive Therapeutics is digitalizing regulatory submission workflows for new product launches. Been looking at how some pharmaceutical teams are validating submission components before health authority review instead of fixing errors post-submission, can share what’s working if useful.
DT Initiative 2: Enhancing Clinical Data Management
What the company is doing
Aquestive Therapeutics enhances its clinical data management processes to centralize and analyze data from ongoing clinical trials. This includes pharmacokinetic (PK) and human factors studies for pipeline products like Anaphylm™. The company aims to improve data quality and accelerate responses to regulatory bodies.
Who owns this
- Chief Medical Officer
- Clinical Data Scientist
- VP Development Operations
Where It Fails
- Raw clinical data fails to sync from Contract Research Organization systems to internal databases.
- Human factors study data contains inconsistent participant entries before analysis.
- Pharmacokinetic study outputs require manual transfer to specialized analysis tools.
- Clinical study reports contain data discrepancies due to unvalidated source data inputs.
Talk track
Looks like Aquestive Therapeutics is enhancing clinical data management processes. Been seeing how some pharmaceutical companies are routing clinical data directly into centralized systems instead of manual transfers, happy to share what we’re seeing.
DT Initiative 3: Implementing Pharmaceutical Serialization and Traceability
What the company is doing
Aquestive Therapeutics implements systems for pharmaceutical product serialization and global traceability within its manufacturing and packaging operations. This ensures compliance with international regulations and supports the secure distribution of its commercialized products. They offer serialization as part of their CDMO services.
Who owns this
- VP of Operations
- Supply Chain Director
- Quality Assurance Manager
Where It Fails
- Unique product identifiers fail during packaging line integration due to system incompatibilities.
- Global traceability reports contain missing or incorrect batch data from manufacturing lines.
- Serialized data fails to transmit to regulatory databases during product release.
- Packaging line errors require manual reconciliation of serialized product counts.
Talk track
Saw Aquestive Therapeutics is implementing pharmaceutical product serialization across its manufacturing facilities. Been looking at how some teams detect identifier discrepancies on packaging lines instead of finding errors post-production, can share what’s working if useful.
DT Initiative 4: Automating Quality Management Workflows
What the company is doing
Aquestive Therapeutics is deploying digital platforms to automate quality event management workflows across its manufacturing and development processes. This includes managing deviations, corrective and preventive actions (CAPAs), and audit findings to maintain high regulatory and internal quality standards. This streamlines operations for both proprietary products and CDMO clients.
Who owns this
- VP Global Quality And Compliance
- Quality Assurance Manager
- Process Owner
Where It Fails
- Quality deviations require manual routing for CAPA approval across departments.
- Audit findings do not propagate to corrective action plans in a timely manner.
- Quality control data fails to integrate with batch release documentation systems.
- Change control processes require manual cross-referencing against quality system documents.
Talk track
Noticed Aquestive Therapeutics is automating quality management workflows. Been seeing how some teams enforce automated routing for quality event escalations instead of relying on manual handoffs, happy to share what we’re seeing.
Who Should Target Aquestive Therapeutics Right Now
This account is relevant for:
- Regulatory Information Management (RIM) system providers
- Clinical Data Management (CDM) platform vendors
- Pharmaceutical Serialization and Traceability solution providers
- Quality Management System (QMS) software for pharma
- Supply Chain visibility and compliance platforms
Not a fit for:
- Generic HR software
- Basic marketing automation tools
- General IT infrastructure services
- Consumer-facing e-commerce platforms
When Aquestive Therapeutics Is Worth Prioritizing
Prioritize if:
- You sell systems that validate regulatory submission components before health authority review.
- You sell platforms that route clinical trial data directly from CROs into centralized internal databases.
- You sell solutions that detect unique product identifier discrepancies on pharmaceutical packaging lines.
- You sell software that enforces automated routing for quality event escalations and CAPA approvals.
- You sell tools that standardize participant data capture fields for human factors studies.
Deprioritize if:
- Your solution does not address any of the breakdowns identified in pharmaceutical development, manufacturing, or regulatory processes.
- Your product is limited to basic data storage without robust validation or integration capabilities.
- Your offering is not built for the strict compliance requirements of the pharmaceutical industry.
Who Can Sell to Aquestive Therapeutics Right Now
Regulatory Information Management Platforms
Veeva Systems - This company provides cloud-based software for the global life sciences industry, including regulatory information management.
Why they are relevant: Aquestive Therapeutics experiences documentation version control issues during multi-country regulatory filings. Veeva RIM can centralize regulatory content, manage submissions, and validate compliance data before health authority review, preventing discrepancies across global markets.
EXTEDO - This company offers eCTD publishing and regulatory information management solutions for the life sciences sector.
Why they are relevant: Health authority feedback for Aquestive Therapeutics requires manual re-categorization and update. EXTEDO's platform can streamline the process of managing regulatory responses and changes, enforcing structured data capture for efficient reconciliation.
Clinical Data Management Systems
Medidata Solutions - This company provides a unified platform for clinical research, including Electronic Data Capture (EDC) and clinical data management.
Why they are relevant: Aquestive Therapeutics' raw clinical data fails to sync efficiently from CRO systems to internal databases. Medidata's platform can ensure seamless, automated data transfer and integration from various trial sources, preventing data discrepancies and delays in analysis.
OpenClinica - This company offers open-source clinical trial software for electronic data capture, clinical data management, and electronic patient-reported outcomes.
Why they are relevant: Human factors study data at Aquestive Therapeutics contains inconsistent participant entries before analysis. OpenClinica can standardize participant data capture fields and enforce data validation rules at the point of entry, improving data quality for regulatory submissions.
Pharmaceutical Serialization and Traceability Solutions
TraceLink - This company provides a network for pharmaceutical supply chain traceability, enabling compliance with global serialization regulations.
Why they are relevant: Aquestive Therapeutics faces challenges when unique product identifiers fail during packaging line integration. TraceLink's platform can detect and prevent serialization errors on packaging lines, ensuring that every product is accurately tagged and tracked for global distribution.
Systech - This company offers brand protection and product authentication solutions, including serialization, traceability, and anti-counterfeiting.
Why they are relevant: Global traceability reports for Aquestive Therapeutics contain missing or incorrect batch data. Systech can validate batch data integrity throughout the manufacturing process and synchronize it with serialized codes, ensuring accurate and compliant reporting across the supply chain.
Quality Management Systems for Pharma
MasterControl - This company provides a cloud-based quality management system specifically designed for life sciences and other regulated industries.
Why they are relevant: Aquestive Therapeutics' quality deviations require manual routing for CAPA approval across departments. MasterControl can automate the routing and approval processes for quality events, ensuring timely and compliant resolution of deviations and corrective actions.
Sparta Systems (Honeywell) - This company offers enterprise quality management software (EQMS) for highly regulated industries, including pharmaceutical manufacturing.
Why they are relevant: Audit findings at Aquestive Therapeutics do not propagate to corrective action plans in a timely manner. Sparta Systems' EQMS can detect gaps between audit findings and assigned actions, enforcing linkage and tracking progress to ensure all compliance issues are addressed.
Final Take
Aquestive Therapeutics is scaling its regulatory submission, clinical data management, manufacturing serialization, and quality management systems to support its pipeline and global market entry. Breakdowns are visible in data synchronization between CROs and internal systems, manual regulatory feedback processing, packaging line serialization failures, and manual quality event routing. This account is a strong fit for vendors offering solutions that prevent data integrity issues, automate compliance workflows, and enforce traceability controls within the highly regulated pharmaceutical lifecycle.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.